The Medicines (Products for Human Use) (Amendments Relating to Fees for Variations) Regulations 2009 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The Medicines (Products for Human Use) (Amendments Relating to Fees for Variations) Regulations 2009 PDF full book. Access full book title The Medicines (Products for Human Use) (Amendments Relating to Fees for Variations) Regulations 2009 by Great Britain. Download full books in PDF and EPUB format.
Author: Great Britain
Publisher:
ISBN: 9780111489109
Category : Law
Languages : en
Pages : 16
Get Book Here
Book Description
Enabling power: Medicines Act 1971, s. 1 (1) (2) & European Communities Act 1972, s. 2 (2) & Finance Act 1973, s. 56 (1) (2). Issued: 10.12.2009. Made: 07.12.2009. Laid: 10.12.2009. Coming into force: 01.01.2010. Effect: S.I. 1994/3144; 2009/389 amended. Territorial extent & classification: E/W/S/NI. General
Author: Great Britain
Publisher:
ISBN: 9780111489109
Category : Law
Languages : en
Pages : 16
Get Book Here
Book Description
Enabling power: Medicines Act 1971, s. 1 (1) (2) & European Communities Act 1972, s. 2 (2) & Finance Act 1973, s. 56 (1) (2). Issued: 10.12.2009. Made: 07.12.2009. Laid: 10.12.2009. Coming into force: 01.01.2010. Effect: S.I. 1994/3144; 2009/389 amended. Territorial extent & classification: E/W/S/NI. General
Author: GREAT BRITAIN.
Publisher:
ISBN: 9780348246049
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
Enabling power: Medicines and Medical Devices Act 2021, ss. 2 (1), 6 (1) (a). Issued: 14.03.2023. Sifted: -. Made: 09.03.2023. Laid: 10.03.2023. Coming into force: 01.04.2023. Effect: S.I. 2016/190 amended. Territorial extent & classification: E/W/S/NI. General
Author: Great Britain
Publisher:
ISBN: 9780111474969
Category : Law
Languages : en
Pages : 72
Get Book Here
Book Description
Enabling power: Medicines Act 1971, s. 1 (1) (2) & European Communities Act 1972, s. 2 (2) & Finance Act 1973, s. 56 (1) (2). Issued: 05.03.2009. Made: 23.02.2009. Laid: 05.03.2009. Coming into force: 01.04.2009. Effect: S.I. 1994/105; 2003/2321 amended & S.I. 2008/552 revoked with savings. Territorial extent & classification: E/W/S/NI. General. Revoked by S.I. 2010/551 (ISBN 9780111494547) with savings
Author: Great Britain
Publisher:
ISBN:
Category : Administrative law
Languages : en
Pages : 2244
Get Book Here
Book Description
Author: Great Britain
Publisher:
ISBN: 9780110187754
Category :
Languages : en
Pages : 8
Get Book Here
Book Description
Enabling power: European Communities Act 1972 , s. 2 (2). Issued: 20.11.2000. Made: 09.11.2000. Laid: 10.11.2000. Coming into force: 01.12.2000. Effect: SI 1995/1116 amended. Territorial extent & classification:E/W/S/N.I. General. Revoked by S.I. 2008/552 (ISBN 9780110810737). EC note: Relates to a procedure laid down in Ch. III of EC Council DIR 75/319/EEC
Author: American Bar Association. House of Delegates
Publisher: American Bar Association
ISBN: 9781590318737
Category : Law
Languages : en
Pages : 216
Get Book Here
Book Description
The Model Rules of Professional Conduct provides an up-to-date resource for information on legal ethics. Federal, state and local courts in all jurisdictions look to the Rules for guidance in solving lawyer malpractice cases, disciplinary actions, disqualification issues, sanctions questions and much more. In this volume, black-letter Rules of Professional Conduct are followed by numbered Comments that explain each Rule's purpose and provide suggestions for its practical application. The Rules will help you identify proper conduct in a variety of given situations, review those instances where discretionary action is possible, and define the nature of the relationship between you and your clients, colleagues and the courts.
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309048370
Category : Medical
Languages : en
Pages : 239
Get Book Here
Book Description
Like many other agencies of the federal government, the Food and Drug Administration (FDA) relies extensively on external advisory committees for independent scientific and technical advice. Recognizing that the existing advisory committee system is essentially sound, this volume recommends ways of enhancing the use of these committees in the evaluation of drugs, biological materials, and medical devices; strengthening the agency's management of the system; and increasing the accountability of the system to the public. In doing so, it examines and makes recommendations on such issues as the recruitment of committee members, the FDA's management of financial conflict of interest and intellectual bias among members, and the operations and management of the advisory committee system.
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309158060
Category : Medical
Languages : en
Pages : 442
Get Book Here
Book Description
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: Great Britain. Medicines Control Agency
Publisher:
ISBN:
Category :
Languages : en
Pages : 9
Get Book Here
Book Description
